BeStock  
Stocks › Biotechnology › ROIV

Roivant Sciences ROIV

US equityMarket cap rank #706Biotechnology
$38.66 −$0.31 (-0.78%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $38.68 +0.06%
Open$38.86
Prev close$38.96
Day range$38.46 – $39.51
Volume3.97M
Market cap$28.01B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$48.90+26.5% vs. price
  • Buy 82%
  • Hold 18%
Low $40.00Now $38.66Avg $48.90High $62.00

Recent rating changes

The last 20 actions on file set price targets from $41.00 to $62.00, averaging $48.41.

DateFirmRatingTarget
13 Nov 2026 Guggenheim BUY $48.00
12 Nov 2026 J.P. Morgan BUY $49.00
10 Nov 2026 H.C. Wainwright BUY $48.00
9 Nov 2026 BofA Securities HOLD $42.00
9 Nov 2026 Citi BUY $56.00
9 Nov 2026 H.C. Wainwright BUY $47.00
9 Nov 2026 J.P. Morgan BUY –
29 Oct 2026 Citi BUY $56.00
28 Oct 2026 Citi BUY $56.00
21 Oct 2026 TD Cowen BUY $62.00
21 Oct 2026 BofA Securities HOLD $41.00
21 Oct 2026 H.C. Wainwright BUY $47.00
12 Oct 2026 Wolfe Research HOLD –
12 Oct 2026 BofA Securities HOLD $41.00
12 Oct 2026 Citi BUY $46.00
25 Sep 2026 Bernstein BUY $41.00
22 Sep 2026 BofA Securities HOLD $41.00
17 Sep 2026 Stifel BUY $51.00
17 Sep 2026 J.P. Morgan BUY –
16 Sep 2026 Stifel BUY $51.00

Discussion

No comments yet — be the first to weigh in on ROIV.

Sign in to join the discussion.

Scroll to Top